secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2025-01-10T23:59:59+00:00
Accession:  0001213900-25-002339
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

CERO Therapeutics issues 16.4M shares and warrants upon warrant exercise for $500K
--------------------------------------------------------------------------------

- Holder exercised 625 Preferred Warrants at $800/sh, paying $500K (20% OID on $625K stated value).
- Series A Preferred shares converted into 16,385,275 common shares of CERO.
- Company issued new warrants to purchase 16,385,275 common shares at $0.0582/sh (Jan 3 closing price).
- Proceeds included in previously reported cash balance as of Jan 7, 2025; exemption under Section 4(a)(2).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025002339/0001213900-25-002339-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025002339/ea0227335-8k_cerotherap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-002339

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer